Carisoprodol is metabolized in the liver primarily by the enzyme CYP2C19, where it is converted into meprobamate, an older muscle relaxant and tranquilizer. This metabolic process contributes to the sedative effects of carisoprodol, as meprobamate is known for its anxiolytic and muscle-relaxing properties. Consequently, the potential for addiction arises due to the euphoric and calming effects associated with meprobamate, making carisoprodol potentially habit-forming as well.
Copyright © 2026 eLLeNow.com All Rights Reserved.